In this study, we aimed to investigate the effects of linagliptin on high glucose-induced podocyte apoptosis and found that linagliptin offers protection against DKD through amelioration of IRS1/insulin signalling in podocytes. The gene discussed is INS; the disease is diabetic kidney disease.